Louisa Galbraith
Partner, Zurich
T +41 58 552 02 98
louisa.galbraith@mll-legal.com
Profile
Louisa Galbraith is a partner in our Zurich office and a member of the firm’s IP team. She represents and advises clients in all aspects of IP with a focus on patents, trademarks, trade secrets and unfair competition law. Louisa has a broad experience in patent and trademark litigation and is a trusted advisor and litigator in the field of pharmaceutical regulatory law. As a life sciences and healthcare enthusiast, Louisa further advises on contractual matters in those fields.
Before joining MLL Legal, Louisa worked as a junior associate for a leading Swiss law firm in Zurich, where she gained experience in the fields of international arbitration and copyright law. While attending the University of St. Gallen, she worked as a research assistant at the chair for public economic law particularly in the fields of procurement law, competition law, environmental law and regulatory law.
Industry Groups
Special Desks
Rankings & Awards


























- “Solution-oriented in the interests of our company” – IP Stars, Rising Star, 2024
- “She has quick comprehension” – IP Stars, Rising Star, 2024
- Louisa Galbraith received the first ever “Rising Star of the Year Award” for Switzerland by Managing IP in 2024
- “Simon Holzer is one of the leading Swiss IP/patents practitioners. He is always calm and measured, and very responsive when needed. He is very easy to work with and he provides excellent legal and commercial advice. I would highly recommend him. Louisa Galbraith is a rising star” – Legal 500 EMEA, Healthcare And Life Sciences, 2024
- Managing IP has recognized Louisa Galbraith as “Rising Star” in their 2023 edition
- “A rising star and de facto partner designate. Her output is of a high quality” – Legal 500 EMEA, IP, 2023
- “Louisa Galbraith is the upcoming rising star of the firm” – Legal 500 EMEA, IP, 2023
- Managing IP has recognized Louisa Galbraith as “Rising Star” in their 2022 edition
- “Louisa Galbraith is a rising star and one to watch in the near future” – Legal 500 EMEA, Healthcare and Life Sciences, 2022
- Louisa Galbraith has been recognised as a “Rising Star” in The Legal 500 EMEA, Healthcare and Life Sciences, 2022
- Managing IP has recognized Louisa Galbraith as “Rising Star” in their 2020/2021 edition
Deals & Cases
- Successfully defended the Swiss SPC for apixaban of Bristol-Myers Squibb in patent revocation proceedings before the Swiss Federal Patent Court and the Swiss Supreme Court. BMS’ SPC protects the client’s blockbuster drug Eliquis, a blood thinner that reduces blood clotting. This leading case dealt for the first time with the implementation of the two landmark decisions G 1/22 and G 2/21 of the Enlarged Board of Appeal of the EPO in Switzerland.
- Enforced Bayer’s EP 2 305 255 concerning a compound of a tosylate salt of the active ingredient sorafenib in Switzerland. The active ingredient forms the basis of Bayer’s drug Nexavar, which is used to treat various types of cancer, including kidney, liver cell and thyroid cancer.
- Representation of Lindt & Sprüngli before the Swiss Federal Supreme Court against copies of the Lindt Gold Bunny offered by Lidl.
Education & Admission
- University of Zurich, CAS in Medlaw (2025)
- Admitted to the bar in Switzerland (2017)
- University of St. Gallen, Master in Law and Economics (2015)
- University of St. Gallen, Bachelor in Law and Economics (2012)
Memberships and public offices
- Board Member of the Biostime Institute Nutrition & Care (BINC) Foundation
- Board Member of the Swiss Group of the International Association for the Protection of Intellectual Property (AIPPI)
- European Patent Lawyers Association (EPLAW)
- Swiss Association for Intellectual Property Law (INGRES)
- International Trademark Association (INTA)
- Zurich Bar Association (ZAV)
- IP Practice group of Zurich Bar Association
Languages
- German
- English
- French
Publications
Assistant
Publications
News Portal
Firm News
Louisa Galbraith received the first ever “Rising Star of the Year Award” for Switzerland by Managing IP in 2024
